Newsroom

Sorted by: Latest

-

Pierre & Vacances - Center Parcs : Chiffre d’affaires du 1er trimestre de l’exercice 2025/2026

PARIS PARIS--(BUSINESS WIRE)--Regulatory News: Franck Gervais, Directeur Général de Pierre & Vacances - Center Parcs (Paris:VAC), a déclaré : « Au premier trimestre de l’exercice 2025/2026, le Groupe Pierre & Vacances-Center Parcs poursuit la croissance de ses activités touristiques, dans la continuité des performances solides enregistrées au cours des exercices précédents, avec une hausse de près de 7% de son chiffre d’affaires et une trajectoire positive pour l’ensemble des indicateur...
-

Pierre & Vacances-Center Parcs: First Quarter 2025/2026 Revenue

PARIS--(BUSINESS WIRE)--Regulatory News: Franck Gervais, CEO of Pierre & Vacances-Center Parcs (Paris:VAC), stated: “The Pierre & Vacances-Center Parcs Group continued to grow its tourism businesses during Q1 2025/2026, in line with the robust performances seen during previous years with a near-7% increase in revenue and positive trends across all performance indicators for each brand. Momentum was driven primarily by the appeal of our offer and the success of recent site openings and e...
-

Bank of New York Mellon UK Regulatory Announcement: FRN Variable Rate Fix

LONDON--(BUSINESS WIRE)--  As Agent Bank, please be advised of the following rate determined on: 1/22/2026 Issue ¦ National Grid Gas PLC - Series 57 GBP 75,000,000 Index-Linked FRN Due 22 Aug 2052     ISIN Number ¦ XS0316596476 ISIN Reference ¦ 31659647 Issue Nomin GBP ¦ 75000000 Period ¦ 2/22/2026 to 8/22/2026   Payment Date 8/24/2026 Number of Days ¦ 181 Rate ¦ 3.18477   Denomination GBP ¦ 100000   ¦ 75000000   ¦       Amount Payable per Denomination ¦ 1592.39   ¦ 1194288.75   ¦       Bank of...
-

SPIE Announces the Best New Products in the Photonics Industry at Its 18th Annual Prism Awards

BELLINGHAM, Wash.--(BUSINESS WIRE)--On 21 January, SPIE, the international society for optics and photonics, recognized the top-rated new optics and photonics products with the industry-focused Prism Awards. The gala evening, held during SPIE Photonics West, marked the Prism Awards’ 18th year of honoring companies that are bringing transformative products to market. Each year, the SPIE Prism Awards reflect the rapidly growing trajectory, exciting latest developments, and rich technical innovati...
-

Ziprasidone (CAS 146939-27-7) Industry Research 2025: Global Market Trends 2019-2024 and Forecasts 2025-2029 - Applications, Manufacturing Method, Patents, Suppliers, Prices, End-users - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Ziprasidone (CAS 146939-27-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. This report on Ziprasidone provides comprehensive insights, including general information, synonyms, chemical composition, safety, hazards, handling, storage, and toxicological and ecological details, along with transport information. This in-depth study serves as a vital resource for und...
-

Amtech Systems to Announce Fiscal 2026 First Quarter Financial Results on February 5, 2026

TEMPE, Ariz.--(BUSINESS WIRE)--Amtech Systems, Inc. ("Amtech") (NASDAQ: ASYS), a manufacturer of equipment and consumables enabling AI semiconductor device packaging and advanced substrate fabrication, will announce financial results for its fiscal 2026 first quarter ended December 31, 2025 on February 5, 2026 after market close. Amtech Systems will host a conference call at 5:00 pm ET on February 5, 2026 to discuss fiscal 2026 first quarter financial results. The call will be available to inte...
-

Georgia ProtonCare Center, Inc. Files Chapter 11 to Facilitate Competitive Sale Process and Enters Into Asset Purchase Agreement With Emory Healthcare

ATLANTA--(BUSINESS WIRE)--Georgia ProtonCare Center Inc. (“GPCC” or “the Company”) announced today that it has entered into an asset purchase agreement with Emory University, by and on behalf of Emory University Hospital Midtown (“Emory”) to purchase substantially all of its assets plus the assumption of certain liabilities. GPCC’s main asset is a proton therapy cancer treatment center (the “Facility”) located in Midtown, Atlanta. Emory clinicians provide the day-to-day care and treatment for p...
-

F/m Investments Files First-of-Its-Kind SEC Application for Tokenized ETF Shares

WASHINGTON--(BUSINESS WIRE)--F/m Investments (“F/m”), an $18 billion investment firm, today filed an exemptive application with the U.S. Securities and Exchange Commission (the “SEC”) seeking permission to record ownership of tokenized shares in the F/m US Treasury 3 Month Bill ETF (TBIL) on a permissioned blockchain ledger. The application is believed to be the first filed by an ETF issuer seeking SEC relief specifically for tokenized shares of a registered investment company. "Tokenization is...
-

Conclusa l'acquisizione di MB Elettronica da parte di Scanfil

CORTONA, Italia--(BUSINESS WIRE)--L'acquisizione dell'azienda italiana MB Elettronica (“MB”) di Cortona, in Toscana, da parte della finlandese Scanfil è stata finalizzata....
-

Risperidone (CAS 106266-06-2) Industry Research 2025: Global Market Trends 2019-2024 and Forecasts 2025-2029 - Applications, Manufacturing Method, Patents, Suppliers, Prices, End-users - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Risperidone (CAS 106266-06-2) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. This report on Risperidone provides comprehensive insights, including general information, synonyms, chemical composition, safety, hazards, handling, storage, and toxicological and ecological details, along with transport information. This in-depth study serves as a vital resource for und...